[FULC] YoY Quarter Result on 30-Jun-2019 [#Q1]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
26-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q1]
Profit Trend
QoQ- 64.26%
YoY- -67.84%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 80,000 880 1,882 4,381 2,000 0 0 -
PBT 55,409 -23,783 -34,070 -19,648 -15,685 -13,169 -7,846 -
Tax 0 525 -24 -28 0 -317 5 -
NP 55,409 -23,783 -34,070 -19,648 -15,685 -13,169 -7,846 -
Tax Rate 0.00% - - - - - - -
Total Cost 24,591 24,663 35,952 24,029 17,685 13,169 7,846 20.95%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 69.26 -2,702.61 -1,810.31 -448.48 -784.25 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.89 -0.38 -0.83 -0.60 -0.66 -0.56 -0.46 -
EPS Diluted 0.87 -0.38 -0.83 -0.60 -0.66 -0.56 -0.46 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.